Contact
Please use this form to send email to PR contact of this press release:
Albireo Granted Orphan Drug Designation by FDA For Lead Product Candidate A4250 for Treatment of Biliary Atresia
TO:
Please use this form to send email to PR contact of this press release:
Albireo Granted Orphan Drug Designation by FDA For Lead Product Candidate A4250 for Treatment of Biliary Atresia
TO: